Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.75B P/E - EPS this Y 300.00% Ern Qtrly Grth -
Income 18.1M Forward P/E -139.67 EPS next Y 68.20% 50D Avg Chg -4.00%
Sales 1.07B PEG 0.92 EPS past 5Y - 200D Avg Chg 1.00%
Dividend N/A Price/Book 5.61 EPS next 5Y 94.90% 52W High Chg -32.00%
Recommedations 2.40 Quick Ratio 2.14 Shares Outstanding 208.07M 52W Low Chg 109.00%
Insider Own 11.93% ROA 2.17% Shares Float 187.18M Beta 1.05
Inst Own 66.68% ROE 5.31% Shares Shorted/Prior 26.54M/23.04M Price 8.38
Gross Margin 82.19% Profit Margin 1.70% Avg. Volume 3,115,700 Target Price 21.93
Oper. Margin 3.49% Earnings Date Nov 4 Volume 3,028,431 Change -4.34%
About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc. News
12:43 PM Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug
08:00 AM Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
10/19/24 FDA not planning to take action against GLP-1 compounders, Endpoints says
10/17/24 3 US Growth Companies With Significant Insider Ownership
10/16/24 Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.
10/15/24 Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation
10/15/24 Do Its Financials Have Any Role To Play In Driving Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Up Recently?
10/14/24 Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
10/14/24 Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
10/14/24 Hims & Hers surges as FDA mulls over compounded drugs limit
10/10/24 WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
10/04/24 Hims & Hers Health Set to Join S&P SmallCap 600
10/04/24 Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list
10/03/24 For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
10/03/24 Stocks to Watch Thursday: Levi Strauss, Hims & Hers, Constellation Brands, Nvidia
10/03/24 Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list
09/18/24 Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
09/18/24 3 US Insider Picks With Earnings Growth Up To 98%
09/16/24 Hims & Hers Health, Inc.'s (NYSE:HIMS) large institutional owners must be happy as stock continues to impress, up 19% over the past week
09/06/24 Why Big Pharma is betting on telehealth strategies
HIMS Chatroom

User Image uyenng25_ Posted - 1 hour ago

$HIMS another one that has been acting incredibly well recently, trying to get a nice flag breakout going at the moment. another name that has been very strong in 2024. Bullish

User Image TheStockTraderHub Posted - 1 hour ago

$HIMS WITH A STRONG CLOSE OVER IT'S CRITICAL $23 RESISTANCE TODAY, WATCH FOR A BREAKOUT TO NEW ALL TIME HIGHS IN COMING DAYS WITH A POTENTIAL TARGET OF $26+. SUPPORT : $22 & $21

User Image BinaryLogic Posted - 1 hour ago

$HIMS

User Image Starfish2024 Posted - 2 hours ago

$HIMS y’all think this could hit $45 after earnings?

User Image Randymarsh710 Posted - 2 hours ago

$HIMS 🚀🚀🚀

User Image WBM912 Posted - 2 hours ago

$HIMS 25 COMING BY 4 AM ❗️❗️❗️❗️

User Image WBM912 Posted - 2 hours ago

$HIMS HOLY SHXT WHAT IS GOING ON WE HEADING TO THE MOON FAST ❗️❗️❗️

User Image Billybobsaget4 Posted - 2 hours ago

$HIMS that’s hot

User Image WBM912 Posted - 3 hours ago

$HIMS YOOOOO IM STILL HERE LETS FUGGINGOOOO❗️❗️❗️

User Image ryan2022 Posted - 4 hours ago

$HIMS I look forward to earnings. Last qtr compound semiglutide accounted for just 5% revenue and they smashed expectations.

User Image BeachbumInvestor Posted - 5 hours ago

$HIMS $mgrx is next... IMO

User Image Gettingthere67 Posted - 6 hours ago

$HIMS Another vote of confidence today in HIMS: https://www.investors.com/research/hims-stock-hims-hers-health-tops-growth-50-list-as-fda-allows-weight-loss-drug/

User Image optionLordX420 Posted - 6 hours ago

$HIMS Ahahhahahahahahahahahhahaahahaha

User Image DipBuyInvester Posted - 7 hours ago

$HIMS AKAN very bullish!! Buy the dip.

User Image MESSPAC Posted - 7 hours ago

$HIMS $25 sounds right

User Image Jacecaudwell Posted - 8 hours ago

$HIMS heading back to 25 before earnings.

User Image crypto_caviar Posted - 8 hours ago

$HIMS

User Image Jerome_powell_ Posted - 8 hours ago

$HIMS squeeze on her knees and begging

User Image squueeze Posted - 8 hours ago

$HIMS close weak, please!

User Image Gettingthere67 Posted - 8 hours ago

$HIMS BofA will have to raise its pt again soon (for third time in two weeks!)

User Image enchbyench Posted - 8 hours ago

$HIMS Bring it.

User Image Tagbat Posted - 8 hours ago

$HIMS thanks for 16%

User Image squueeze Posted - 8 hours ago

$HIMS lol

User Image flying_bird Posted - 8 hours ago

$PTPI $HIMS trading at $ 23. Shall we expect $PTPI trade above $20 after FDA approval?

User Image enchbyench Posted - 8 hours ago

$HIMS do you think they 🩳 can reattach their face.

User Image TomCruiseShip Posted - 8 hours ago

$HIMS wow

User Image Battaash Posted - 9 hours ago

$HIMS We should hire David Goggins for Hard Mints marketing 💪🍆

User Image Gettingthere67 Posted - 9 hours ago

$HIMS My two main holdings HIMS and $POWL having a great day... just don't understand why POWL has so very few Watchers on here - it's as equally successful and promising a company as HIMS (just look at its charts and ERs).

User Image BuyNowUnlimited Posted - 9 hours ago

$HIMS how is $hims not down 10% on this news , shocking , lucky day for us

User Image Tagbat Posted - 9 hours ago

$HIMS alright $23 has been breached. ATH incoming + $25 🚀. 🧲 $30 + soon

Analyst Ratings
B of A Securities Buy Sep 13, 24
Needham Buy Aug 22, 24
Deutsche Bank Hold Aug 7, 24
Piper Sandler Neutral Aug 6, 24
Truist Securities Hold Jul 18, 24
TD Cowen Buy Jul 11, 24
Piper Sandler Neutral Jul 11, 24
Jefferies Hold Jun 27, 24
B of A Securities Buy Jun 13, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jan 25 Sell 9.06 195,728 1,773,296 51,653 01/29/24
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jan 25 Option 2.43 195,728 475,619 66,753 01/29/24
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Dec 27 Sell 9.03 54,882 495,584 51,653 12/29/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Dec 27 Option 2.43 54,882 133,363 73,085 12/29/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Nov 30 Sell 9.02 28,100 253,462 12/15/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Nov 30 Option 2.43 28,100 68,283 24,300 12/15/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Dec 04 Sell 8.87 27,399 243,029 382,574 12/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Dec 04 Option 0.4 3,624 1,450 407,473 12/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Nov 06 Sell 6.83 27,399 187,135 403,849 11/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Nov 06 Option 0.4 27,399 10,960 412,982 11/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Oct 05 Sell 6.2309 9,133 56,907 403,849 10/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Oct 03 Sell 6.25 18,266 114,162 412,982 10/06/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Sep 20 Sell 6.27 15,504 97,210 168,089 09/22/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Sep 20 Sell 6.28 6,794 42,666 150,982 09/22/23
O'Keefe Lynne Chou Director Director Sep 19 Sell 6.31 10,045 63,384 09/20/23
Becklund Irene PAO PAO Sep 19 Sell 6.31 10,596 66,861 5,494 09/20/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Sep 01 Sell 6.85 27,399 187,683 399,352 09/06/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Aug 21 Sell 6.9154 6,698 46,319 125,016 08/22/23
O'Keefe Lynne Chou Director Director Aug 09 Sell 7.15 45,748 327,098 08/16/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Aug 08 Sell 9.04 6,900 62,376 08/09/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Aug 08 Option 2.43 6,900 16,767 6,900 08/09/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 06 Sell 8.68 9,133 79,274 454,150 07/10/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 06 Option 0.4 9,133 3,653 463,283 07/10/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 03 Sell 9.03 18,266 164,942 454,150 07/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 03 Option 0.4 18,266 7,306 463,283 07/06/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 06 Sell 9.13 71,933 656,748 385,947 06/08/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 06 Option 2.43 73,942 179,679 457,880 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jun 06 Sell 9.1 18,266 166,221 422,260 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jun 06 Option 0.4 11,614 4,646 431,393 06/08/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 02 Sell 9.0359 2,009 18,153 383,938 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 09 Sell 10.78 12,966 139,773 422,579 05/11/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 09 Option 0.4 25,932 10,373 435,545 05/11/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 05 Sell 11.93 31,998 381,736 403,547 05/09/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 05 Option 0.4 19,032 7,613 422,579 05/09/23
Becklund Irene PAO PAO Apr 04 Sell 10.3 15,890 163,667 04/06/23
Becklund Irene PAO PAO Apr 04 Option 1.75 567 992 567 04/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Apr 04 Sell 10 30,065 300,650 445,778 04/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Mar 20 Sell 9.542 9,333 89,055 475,843 03/21/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Mar 16 Sell 9.91 22,119 219,199 485,176 03/20/23
Becklund Irene PAO PAO Mar 17 Sell 9.79 6,170 60,404 15,323 03/20/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Mar 17 Sell 9.9 15,720 155,628 99,013 03/20/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Mar 17 Sell 9.79 13,745 134,564 168,089 03/20/23
Maltz Jules A. 10% Owner 10% Owner Mar 02 Sell 10.1 36,820 371,882 03/06/23
Bard Alex Director Director Mar 01 Sell 11.17 2,819,109 31,489,448 7,349,710 03/03/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Jan 17 Sell 7.51 2,000 15,020 287,089 01/19/23
O'Keefe Lynne Chou Director Director Sep 20 Sell 5.68 10,046 57,061 09/21/22
Becklund Irene PAO PAO Sep 20 Sell 5.68 10,668 60,594 6,978 09/21/22
Becklund Irene PAO PAO Jul 05 Sell 5 19,331 96,655 13,717 07/06/22
O'Keefe Lynne Chou Director Director Jun 21 Sell 4.35 10,045 43,696 06/22/22
Maltz Jules A. Director Director Jun 14 Buy 3.66 75,000 274,500 125,000 06/16/22